Innopeutics
@innopeutics.com
이노퓨틱스 혁신 신약 개발 (주)이노퓨틱스는 알츠하이머병, 파킨슨병과 같은 퇴행성 뇌질환과, 암, 자가면역질환 치료를 위한 유전자치료제를 개발하고 있습니다. 경영진 소개 | Management 김태균 대표이사 | CEO김태균 대표이사는 식품의약품안전처에서 첨단바이오의약품(유전자치료제, 세포치료제, 조직공학제제) 허가심사, 연구업무에 20년간 종사한 경험이 있으며, 바이오 벤처기업에 근무하며 바이오의약품 GMP 제조시설을 구축하고 개발제품의 임상시험계획(IND) 승인을 조기에 받을 수 있도록 기여한 경험이 있습니다. 또한, 중견 [...]
Innopeutics's Company Logos
Innopeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1D4FC4
Persian Blue
29, 79, 196
222, 74, 44
85, 60, 0, 23
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#6440A4
Royal Purple
100, 64, 164
262, 44, 45
39, 61, 0, 36
About Innopeutics
Innopeutics Co. is dedicated to innovative therapeutics to combat various human diseases. Specializing in degenerative brain disorders like Alzheimer's and Parkinson's, as well as genetic therapies for cancer and autoimmune diseases, Innopeutics Co.
is at the forefront of gene therapy development. With a focus on the Adeno-associated Virus (AAV) vector technology, their products boast high safety, efficiency, and long-term gene expression. Led by a team with extensive experience in bio-pharmaceuticals, including CEO Kim Taegyun and CSO Lee Sanghoon, who have a strong background in clinical research and development.
Innopeutics Co. welcomes talent to join their team, offering opportunities in research, development, manufacturing, and various support roles. For those passionate about advancing healthcare, Innopeutics Co.
is a promising place to make a difference. Contact them now to be part of their groundbreaking journey
Company type
Privately Held
Year founded
2019
Company size
11-50 employees
